<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-107273</identifier>
<setSpec>0214-1221</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Our experience with the use of alpha-lithic therapy in the treatment of voiding dysfunction</dc:title>
<dc:description xml:lang="en">Introduction. Dysfunctional voiding (DV) is due to a dysfunction in the pelvis floor muscles caused by hyperactivity of the urethral sphincter and the musculature of this zone during the voiding phase of the micturition cycle. The treatments used are recommending correct micturition habits, biofeedback and pelvic relaxation exercises. Currently, drugs are also used, such as alpha lithic drugs and injection of botulinic toxin, however its experience in children is limited. Objectives. Show our experience with the use of alpha-lithics inpatients with DV. Material and methods. Review of patients with DV treated with alpha-lithics in our institution .Results. 6 patients with DV were treated with alpha-lithics (Alfuzosin or Doxazosin). Girl (12 years) with Wolfram Syndrome with significant post-void residual urine, who initially rejected intermittent catéter. Residual urine decreases slightly with treatmente, but isn´t (..) (AU)</dc:description>
<dc:creator>Gracia Romero, J</dc:creator>
<dc:creator>Calleja Aguayo, E</dc:creator>
<dc:creator>Rihuete Heras, M. A</dc:creator>
<dc:creator>Delgado Alvira, R</dc:creator>
<dc:creator>Ruiz de Temiño Bravo, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. El vaciamiento disfuncional (VD) se debe a una disfunción en la musculatura del suelo pélvico, ocasionado por una hiperactividad del esfínter uretral y de la musculatura de esa zona durante la fase de vaciado del ciclo miccional. Los tratamientos utilizados son recomendar hábitos miccionales correctos, biofeedback y ejercicios de relajación pélvica. En la actualidad, también se utilizan fármacos, como alfalíticos e injección de toxina botulínica, pero su experiencia en niños es escasa. Objetivos. Mostrar nuestra experiencia con el uso de alfalíticos en pacientes con VD. Material y métodos. Revisión de los pacientes con VD tratados con alfa-líticos en nuestro servicio. Resultados. 6 pacientes con VD fueron tratados con alfa-líticos(Alfuzosina o Doxazosina). Niña (12 años) con síndrome de Wolfram (..) (AU)</dc:description>
<dc:source>Cir Pediatr;23(4): 197-200, oct. 2010.</dc:source>
<dc:identifier>ibc-107273</dc:identifier>
<dc:title xml:lang="es">Nuestra experiencia con el uso de alfa-líticos en el tratamiento de la disfunción de vaciado</dc:title>
<dc:subject>^d14952^s22027</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d320^s22073</dc:subject>
<dc:subject>^d23500^s22074</dc:subject>
<dc:subject>^d14924^s22057</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d2715</dc:subject>
<dc:subject>^d29144^s22057</dc:subject>
<dc:subject>^d30747^s22079</dc:subject>
<dc:subject>^d4855^s22057</dc:subject>
<dc:subject>^d14954^s22021</dc:subject>
<dc:type>article</dc:type>
<dc:date>201010</dc:date>
</metadata>
</record>
</ibecs-document>
